T-cell gene therapy (California Institute of Technology)

N/A

Report date: 2025/03/20 09:36:41

Base Information

Drug NameT-cell gene therapy (California Institute of Technology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalifornia Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesCalifornia Institute Of Technology
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A